Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZIM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-23
MYLAN
Dec-18
ZIM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3883,967-   
Low Rs672,184-   
Sales per share (Unadj.) Rs81.81,825.4-  
Earnings per share (Unadj.) Rs5.049.6-  
Cash flow per share (Unadj.) Rs8.6391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs41.11,974.7-  
Shares outstanding (eoy) m48.73514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.7 165.3%   
Avg P/E ratio x45.462.0 73.2%  
P/CF ratio (eoy) x26.57.9 337.0%  
Price / Book Value ratio x5.51.6 355.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m11,0961,582,214 0.7%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m4930-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m3,985939,158 0.4%  
Other income Rs m640-   
Total revenues Rs m4,049939,158 0.4%   
Gross profit Rs m520243,019 0.2%  
Depreciation Rs m175175,847 0.1%   
Interest Rs m5645,170 0.1%   
Profit before tax Rs m35422,002 1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m109-3,500 -3.1%   
Profit after tax Rs m24425,502 1.0%  
Gross profit margin %13.025.9 50.4%  
Effective tax rate %30.9-15.9 -194.2%   
Net profit margin %6.12.7 225.8%  
BALANCE SHEET DATA
Current assets Rs m1,909524,425 0.4%   
Current liabilities Rs m1,108382,364 0.3%   
Net working cap to sales %20.115.1 133.0%  
Current ratio x1.71.4 125.7%  
Inventory Days Days1984 23.3%  
Debtors Days Days87293 934.9%  
Net fixed assets Rs m1,569182,181 0.9%   
Share capital Rs m487500 97.4%   
"Free" reserves Rs m1,5160-   
Net worth Rs m2,0031,015,998 0.2%   
Long term debt Rs m2461,096,588 0.0%   
Total assets Rs m3,4792,725,301 0.1%  
Interest coverage x7.31.5 493.7%   
Debt to equity ratio x0.11.1 11.4%  
Sales to assets ratio x1.10.3 332.4%   
Return on assets %8.62.6 332.7%  
Return on equity %12.22.5 485.9%  
Return on capital %18.23.2 572.2%  
Exports to sales %81.10-   
Imports to sales %12.20-   
Net fx Rs m2,7960-   
CASH FLOW
From Operations Rs m375195,157 0.2%  
From Investments Rs m-362-100,875 0.4%  
From Financial Activity Rs m5-90,916 -0.0%  
Net Cashflow Rs m301,617 1.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ZIM LABORATORIES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ZIM LABORATORIES With: CAPLIN POINT  AMI ORGANICS  TORRENT PHARMA  BH.IMMUN&BIO  GUJ.TERC LAB  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.